Authors
This work identifies 2a as a potent, and competitive urease inhibitor. The integrated experimental, ADMET and computational strategy provides a robust molecular blueprint for its activity, positioning it as a promising lead candidate for developing new therapeutic agents against urease-related pathologies.
No takes yet. Share an insight, caveat, or question.
Ullah et al. (2026) studied this question.